CYSTIC FIBROSIS FOUNDATION
Data sourced from IRS 990 public filings
CYSTIC FIBROSIS FOUNDATION TO CURE CF AND PROVIDE ALL PEOPLE WITH CF THE OPPORTUNITY TO LEAD LONG, FULFILLING LIVES BY FUNDING RESEARCH AND DRUG DEVELOPMENT, PARTNERING WITH THE CF COMMUNITY, AND ADVANCING HIGH-QUALITY, SPECIALIZED CARE.
CYSTIC FIBROSIS FOUNDATION has received 270 grants from 141 known foundation funders. Revenue increased from $292,016,280 in 2023 to $355,798,320 in 2024. Most recent reported revenue: $355,798,320.
Annual Revenue
$355,798,320
Known Funders
141
Grants Received
270
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $355,798,320 | $439,138,919 | $4,986,222,387 |
| 2023 | $292,016,280 | $443,404,599 | $4,885,921,122 |
| 2022 | $248,630,352 | $396,664,114 | $4,735,058,992 |
| 2021 | $417,237,551 | $375,611,186 | $5,691,109,976 |
| 2020 | $800,629,953 | $381,380,991 | $5,369,999,661 |
| 2019 | $605,778,425 | $348,650,099 | $4,476,511,082 |
| 2018 | $275,790,756 | $337,912,568 | $4,013,935,956 |
| 2017 | $275,482,021 | $292,766,690 | $4,401,077,858 |
Top Funders
CHARLESTON SC, SC
CHARLESTON SC, SC
JENKINTOWN, PA
HUDSON, OH
WALTHAM, MA
ALEXANDRIA, VA
JENKINTOWN, PA
SOUTHEASTERN, PA
Boston, MA
SOUTHEASTERN, PA
Showing top 10 of 141 funders.
Key Personnel
From 2024 IRS 990 filing
GENTIANA S AROVAS
MANAGING DIRECTOR, INVESTMENTS OPERATIONS
ERIC KOEHRSEN
MANAGING DIRECTOR, INVESTMENTS
ENRIQUE LIN SHIAO PHD
Principal of Mission Related Investments
EARL A LEE
MANAGING DIRECTOR, INVESTMENTS
ANDREW LEWIS
MANAGING DIRECTOR, INVESTMENTS
STEVEn ROWE MD
EVP, Chief Scientific Officer
JOHN P CLANCY MD
SVP, CLINICAL RESEARCH
JOHN C MAHLER JR MD
CHIEF INVESTMENT OFFICER
BRUCE MARSHALL MD
Chief Medical Officer Ending 7/1/2024
ALBERT FARO MD
Chief Medical Officer Beg. 7/1/2024
Showing 10 of 29 key personnel.
Frequently Asked Questions
Other Nonprofits in Maryland
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.